Integra LifeSciences Releases Vu aPOD Prime IBF for Anterior Lumbar Fusions

Integra LifeSciences announced the market release of its Integra Vu aPOD Prime Intervertebral Body Fusion Device designed for anterior lumbar fusions.

Advertisement

The device has received clearance from the Food and Drug Administration and includes a zero-profile design utilizes two screws to secure the IBD in its functional position, thus eliminating the need for supplemental fixation implants. The device is now fully available in the United States.

More Articles on Spine Devices:

17 Spine Devices Receive FDA 510(k) Clearance in March

Life Spine Reports 37.9% Q1 Growth

Amedica Launches Alloraft Products for Spinal Surgery

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.